Business Services Industry
Imatron Announces EBT Scanner Sale to BodyScan Imaging LLC in Kansas City, Missouri
Business Wire, July 18, 2000
Business Editors/Medical Writers
SO. SAN FRANCISCO, Calif.--(BUSINESS WIRE)--July 18, 2000
Imatron Inc. (Nasdaq:IMAT) announced today that it has sold an Electron Beam Tomography (EBT) scanner to BodyScan Imaging LLC in Kansas City, Missouri. This system sale will be reflected in the Company's third quarter financial results.
BodyScan Imaging LLC will provide imaging services to detect coronary artery disease, carotid artery disease, lung cancer and osteoporosis. In addition, BodyScan Imaging will offer electron beam angiography (EBA). BodyScan Imaging will market its preventive health services to both physicians and the general public. The center will be located in Kansas City, Missouri and will serve both Kansas City, Missouri and Kansas and the entire Western Missouri area. The facility is expected to be operational in September 2000. In addition to this center, a number of other BodyScan Imaging centers are in the planning and development stage.
- Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »
Anthony Sciuto, President of BodyScan Imaging LLC, stated, "We are looking forward to opening our first diagnostic center in Kansas City, Missouri. We are forging important medical alliances both in Kansas City, Missouri and Kansas and are expanding this effort to build a strong support base for our success. The expansion of BodyScan Imaging demonstrates our firm belief in and commitment to Imatron's EBT technology as the 'gold standard' for cardiac diagnostics in preventive medicine."
Dr. Julie Keck, Ph.D., Director of Medical Services, stated, "We are pleased to bring Imatron's EBT scanner to Kansas City and offer the public and the medical community leading-edge technology to assist physicians in detecting coronary artery disease and lung cancer, among other preventable and treatable diseases. After extensive consideration of the potential life-saving benefits of this state-of-the-art technology, and the significant business opportunity presented by owning and operating an EBT scanner, we are looking forward to making this technology accessible to the Western Missouri area."
For additional information about BodyScan Imaging, visit the company's website at www.bodyscanimaging.com.
S. Lewis Meyer, Imatron's CEO, commented, "In previous announcements of EBT scanner sales, we have highlighted the significance of bringing local medical expertise and private capital together to create a strong regional business model. BodyScan Imaging LLC is an excellent example of precisely this marriage between financial resources and healthcare experience in action. We are now seeing this type of strategy replicated in a wide variety of situations across the country. It is very encouraging to see Imatron's second fiscal quarter sales momentum continuing into the third quarter. We are solidly on schedule to meet or exceed our revenue objectives and to report increasingly profitable quarterly operations throughout the 2000 fiscal year."
For additional information about Imatron, visit the Company's web site at www.imatron.com.
Imatron Inc. is primarily engaged in designing, manufacturing, marketing, and supporting high performance electron beam tomography (EBT) scanners based on the Company's proprietary EBT technology. Imatron's EBT scanner is now in use at more than 130 major medical facilities and imaging centers around the world, including the Mayo Clinic, Cedars-Sinai Medical Center, Abbott-Northwestern Hospital, Mount Sinai Medical Center, University of Iowa, National Institutes of Health, UCLA Medical Center, St. Francis Hospital, Stanford University, University of Pittsburgh Medical Center, Edward Cardiovascular Institute, Michigan Heart Imaging, Ohio Heart, University of Illinois, Arizona Heart Institute, Alfried Krupp Krankenhaus, Essen, Landeskrankenhaus in Graz, Austria, Cardiology Research Centre in Moscow, Russia, FAU Erlangen-Nurnberg in Erlangen, Germany, Beijing Hospital in China, HeartScan Imaging, Cooper Clinic, HealthScan of La Jolla, LifeScore of San Diego and HealthScan of Plano (Dallas).
Except for the historical information contained herein, the matters discussed in this news release may contain forward-looking statements that are based on current expectations and estimates about the industry in which Imatron operates, the estimated impact of certain technological advances, the estimated impact of published research studies on scanner sales and procedures, as well as management's beliefs and assumptions. It is important to note that the Company's actual results could differ materially from those projected in such forward-looking statements. The factors that could cause actual results to differ materially include, among others; failed clinical demonstration of certain asserted technological advantages and diagnostic capabilities; reliance on product distributors; competition in the diagnostic imaging market; failure to improve product reliability or introduce new product models and enhancements; delays in production and difficulty in obtaining components and sub-assemblies from limited sources of supply; inability to meet cash-on-delivery or prepayment terms from vendors; determinations by regulatory and administrative government authorities; patent expiration and denial of patent applications; the high cost of the scanner as compared to commercially available CT scanners; and the risk factors listed from time to time in the Company's Securities and Exchange Commission reports, including their reports of Form 10-K for their current fiscal year.
COPYRIGHT 2000 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning